IMMUNOHISTOCHEMICAL ANALYSIS OF GAMMA CATENIN IN WILMS' TUMORS

REFERENCES

• Uemura T. The cadherin superfamily at the synapse: more members, more missions. Cell 1998; 93: 1095–1098
   PubMedGoogle Scholar
• Zhou Y N, Wu Z D, Xu C P, Fang D C. E-cadherin-catenin complex in gastric carcinom. Shijle Huaren Xlaohua Zazhi 2002; 10: 436–440
   Google Scholar
• Cowin P, Karpell H P, Franke W W, Tamkun J, Hynes R O. Plakoglobin: a protein common to different kinds of intracellular adhering junction. Cell 1986; 46: 1063–1073
   PubMed Web of Science ®Google Scholar
• Ben-Ze'ev A, Geiger B. Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr Opin Cell Biol 1998; 10: 629–639
   PubMed Web of Science ®Google Scholar
• Bullions L C, Levine A J. The role of β-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol 1998; 10: 81–87
   PubMedGoogle Scholar
• Ueda G, Sunakawa H, Nakamori K, Shinya T, Tsuhako W, Tamura Y, Kosuqi T, Sato N, Oqi K, Hiratsuka H. Aberrant expression of beta-and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2006; 35(4)356–361
   Google Scholar
• Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B, Ben-Zeev A. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol 1998; 141: 1433–1448
   PubMed Web of Science ®Google Scholar
• Simcha I, Geiger B, Yehuda-Levenberg S, Salomon D, Ben-Zeev A. Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J Cell Biol 1996; 133: 199–209
   PubMed Web of Science ®Google Scholar
• Matsunaga E. Genetics of Wilms, tumor. Hum Genet 1981; 57(3)231–246
   Google Scholar
• Exelby P R. Wilms' tumor: clinical evaluation and treatment. Urol Clin North Am 1991; 18(3)589–597
   Google Scholar
• Breslow N E, Langholz B. Childhood cancer incidence: geographical and temporal variations. Int J Cancer 1983; 15: 703–716
   Google Scholar
• Hosono S, Gross I, English M A, Hajra K M, Fearon E R, Licht J D. E-cadherin is a WT1 target gene. J Biol Chem 2000; 275: 10943–10953
   PubMed Web of Science ®Google Scholar
• Nichols K E, Re G G, Yan Y X, Garvin A J, Haber D A. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. Cancer Res 1995; 55: 4540–4543
   PubMed Web of Science ®Google Scholar
• Werner H, Re G G, Drummond I A, et al. Increased expression of the insulin-like growth factor I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms' tumor gene product. Proc Natl Acad Sci USA 1993; 90: 5828–5832
   PubMed Web of Science ®Google Scholar
• Wang Z Y, Madden S L, Deuel T F, Rauscher F J, III. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 1992; 267: 21999–22002
   PubMed Web of Science ®Google Scholar
• Gashler A L, Swaminathan S, Sukhatme V P. A novel repression module, an extensive activation domain, and a bipartite nuclear factorEgr-1. Mol Cell Biol 1993; 13: 4556–4571
   PubMedGoogle Scholar
• Ryan G, Steele-Perkins V, Morris J F, Rauscher F J, III, Dressler G R. Repression of Pax-2 by Wt1 during normal kidney development. Development 1995; 121: 867–875
   PubMed Web of Science ®Google Scholar
• Kim J, Prawitt D, Bardeesy N, et al. The Wilms' tumor suppresor gene (wt1) product regulates Dax-I gene expression during gonadal differentitation. Mol Cell Biol 1999; 19: 2289–2299
   PubMed Web of Science ®Google Scholar
• Lee S B, Huang K, Palmer R, et al. The Wilms' tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 1999; 98: 663–673
   PubMed Web of Science ®Google Scholar
• Basta-Jovanovic G, Radojevic S, Djuricic S, Savin M, Skodric S, Bunjevacki G, Hadzi-Djokic J, Nesic V. Adhesion molecules in Wilms' tumor: expression and significance of beta-catenin (part II). Srp Arh Celok Lek 2003; 131: 73–76
   Google Scholar
• Basta-Jovanovic G, Radojevic S, Djuricic S. Adhesion molecules in Wilms' tumor (part I). Srp Arh Celok Lek 2003; 131: 69–72
   Google Scholar
• Koesters R, Niggli F, Doebertiz von Knebel M, Stalmach T. Nuclear accumulation of β-catenin protein in Wilms' tumours. J Pathol 2002; 199: 68–76
   Google Scholar
• Vujanic M G, Sandstedt B, Harms D, Kelsey A, Leuschner I, de Kraker J. Revised International Society of Pediatric Oncology (SIOP) working classification of renal tumor of childhood. Med Pediatr Oncol 2002; 38(2)70–82
   Google Scholar
• Syrigos K N, Harrington K, Waxman J, Krausz T, Pignatelli M. Altered γ-catenin expression correlates with poor survival in patients with bladder cancer. J Urol 1998; 160: 1889–1893
   PubMed Web of Science ®Google Scholar
• Shimazui T, Schalken J A, Giroldi L A, et al. Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120cas) in bladder tumors. Cancer Res 1996; 56: 4154–4158
   PubMed Web of Science ®Google Scholar
• Cerrato A, Fulciniti F, Avallone A, Benincasa G, Palombini L, Grieco M. β-and γ-catenin expression in thyroid carcinomas. J Pathol 1998; 185: 267–272
   Google Scholar
• Pantel K, Passlick B, Vogt J, et al. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol 1998; 16: 1407–1413
   PubMed Web of Science ®Google Scholar
• Winn R A, Bremnes R M, Bemis L, et al. γ-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 2002; 21: 7497–7506
   PubMed Web of Science ®Google Scholar
• Buchner A, Oberneder R, Riesenberg R, Keiditsch E, Hofstetter A. Expression of plakoglobin in renal cell carcinoma. Anticancer Res 1998; 1: 4231–4235
   Google Scholar
• Ramburan A, Hadley G P, Govender D. Expression of E-cadherin, cadherin-11, alpha-, beta-and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome. Pathology 2006; 38: 39–44
   Web of Science ®Google Scholar
• Alami J, Wiliams B R, Yeger H. Differential expression of E-cadherin and beta-catenin in primary and metastatic Wilms' tumours. Mol Pathol 2003; 56: 218–225
   Google Scholar
• Radojević S. Wilms' tumor: significance and of immunohistochemical investigations. MSc Thesis, Medical Faculty, University of Belgrade. 2002
   Google Scholar
• Clairotte A, Lascombe I, Fauconnet S, Mauny F, Felix S, Algros M P, Bittard H, Kantelip B. Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors. Am J Clin Pathol 2006; 125: 119–126
   PubMed Web of Science ®Google Scholar
• Karayiannakis A J, Syrigos K N, Polychronidis A, Simopoulos C. Expression patterns of alpha-, beta-and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Anticancer Res 2001; 21: 4127–4134
   PubMed Web of Science ®Google Scholar
• Lee Y C, Wu C T, Chen C S, Hsu H H, Chang Y L. The significance of E-cadherin and alpha-, beta-, and gamma-catenin expression in surgically treated non-small lung cancers of 3 cm or less in size. J Thorac Cardiovasc Surg 2002; 123: 502–507
   PubMed Web of Science ®Google Scholar
• Moreno-Bueno G, Hardisson D, Sarrio D, Sanchez C, Cassia R, Prat J, Herman J G, Esteller M, Matias-Guiu X, Palacios J. Abnormalities of E-cadherin-and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol 2003; 199: 471–478
   PubMed Web of Science ®Google Scholar
• Syrigos K N, Harrington K, Waxman J, Krausz T, Pignatelli M. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer. J Urol 1998; 160: 1889–1893
   PubMed Web of Science ®Google Scholar
• Toyoda E, Doi R, Koizumi M, Kami K, Ito D, Mori T, Fujimoto K, Nakajima S, Wada M, Imamura M. Analysis of E-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell lines. Pancreas 2005; 30: 168–173
   Google Scholar